Pharmacological interventions for prevention and management of delirium in intensive care patients: a systematic overview of reviews and meta-analyses.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
19 02 2019
Historique:
entrez: 21 2 2019
pubmed: 21 2 2019
medline: 25 2 2020
Statut: epublish

Résumé

We assessed the evidence from reviews and meta-analyses of randomised clinical trials on the effects of pharmacological prevention and management of delirium in intensive care unit (ICU) patients. We searched for reviews in July 2017 in: Cochrane Library, MEDLINE, Embase, Science Citation Index, BIOSIS Previews, CINAHL and LILACS. We assessed whether reviews were systematic according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and assessed the methodological quality using ROBIS. Primary outcomes: all-cause mortality, serious adverse events, prevention of delirium and management of delirium. quality of life; non-serious adverse events and cognitive function. We included 378 reviews: 369 narrative reviews, eight semisystematic reviews which failed on a maximum of two arbitrary PRISMA criteria and one systematic review fulfilling all 27 PRISMA criteria. For the prevention of delirium, we identified the one systematic review and eight semisystematic reviews all assessing the effects of alpha-2-agonists. None found evidence of a reduction of mortality (systematic review RR 0.99, 95% CI 0.79 to 1.24). The systematic review and three semisystematic reviews found no evidence of an effect for the prevention of delirium (systematic review RR 0.85, 0.63 to 1.14). Conversely, four semisystematic reviews found a beneficial effect. Serious adverse events, quality of life, non-serious adverse events and cognitive function were not assessed. We did not identify any systematic or semisystematic reviews addressing other pharmacological interventions for the prevention of delirium. For the management of manifest delirium, we did not identify any systematic or semisystematic review assessing any pharmacological agents. Based on systematic reviews, the evidence for the use of pharmacological interventions for prevention or management of delirium is poor or sparse. A systematic review with low risk of bias assessing the effects of pharmacological prevention of delirium and management of manifest delirium in ICU patients is urgently needed. CRD42016046628.

Identifiants

pubmed: 30782910
pii: bmjopen-2018-024562
doi: 10.1136/bmjopen-2018-024562
pmc: PMC6377549
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e024562

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: MB, MOC, JCJ, AP and JW had financial support from the public Innovation Fund Denmark; AP is head of research at the Dept. of Intensive Care unit at Rigshospitalet. The department receives support for research from CSL Behring, Fresenius Kabi and Ferring Pharmaceuticals. AP and JW are members of the AID-ICU steering group (NCT03392376); no other relationships or activities that could appear to have influenced the submitted work.

Références

J Am Geriatr Soc. 2005 Oct;53(10):1658-66
pubmed: 16181163
Crit Care Med. 2004 Apr;32(4):955-62
pubmed: 15071384
Intensive Care Med. 2004 Mar;30(3):444-9
pubmed: 14685663
Neurotherapeutics. 2012 Jan;9(1):158-75
pubmed: 22270810
J Neurosurg Anesthesiol. 2017 Apr;29(2):132-139
pubmed: 26641648
JAMA. 2009 Feb 4;301(5):489-99
pubmed: 19188334
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
Ann Pharmacother. 2011 Oct;45(10):1217-29
pubmed: 21934036
JAMA. 2007 Dec 12;298(22):2644-53
pubmed: 18073360
Psychosomatics. 2004 Jul-Aug;45(4):297-301
pubmed: 15232043
J Surg Res. 2013 Dec;185(2):833-43
pubmed: 23910886
BMJ. 2009 Jul 21;339:b2700
pubmed: 19622552
Crit Care Med. 2013 Jan;41(1):263-306
pubmed: 23269131
PLoS One. 2013;8(3):e59202
pubmed: 23544056
J Clin Diagn Res. 2014 Sep;8(9):GC04-7
pubmed: 25386451
J Clin Epidemiol. 2008 Jan;61(1):64-75
pubmed: 18083463
Ger Med Sci. 2010 Feb 02;8:Doc02
pubmed: 20200655
Intensive Care Med. 2007 Oct;33(10):1726-31
pubmed: 17549455
J Cardiothorac Surg. 2012 Mar 21;7:25
pubmed: 22436170
Syst Rev. 2016 May 04;5:75
pubmed: 27146132
Crit Care Med. 2010 Feb;38(2):419-27
pubmed: 19915454
BMJ. 2013 Jul 19;347:f4501
pubmed: 23873947
Crit Care Med. 2018 Sep;46(9):e825-e873
pubmed: 30113379
PLoS One. 2015 Jun 10;10(6):e0123090
pubmed: 26062023
Crit Care Med. 2016 Mar;44(3):583-91
pubmed: 26540397
JAMA. 2001 Dec 5;286(21):2703-10
pubmed: 11730446
Intensive Care Med. 2009 Feb;35(2):282-90
pubmed: 18795253
Crit Care Med. 2007 Jan;35(1):112-7
pubmed: 17133176
Crit Care Med. 2010 Jul;38(7):1513-20
pubmed: 20473145
Intensive Care Med. 2018 Jul;44(7):1081-1089
pubmed: 29767323
Intensive Care Med. 2001 Dec;27(12):1892-900
pubmed: 11797025
Ann Intern Med. 2012 Sep 18;157(6):429-38
pubmed: 22945832
Neurocrit Care. 2018 Feb;28(1):12-25
pubmed: 28547318
Lancet. 2010 Feb 6;375(9713):475-80
pubmed: 20116842
QJM. 2010 Apr;103(4):243-51
pubmed: 20139102
Am J Psychiatry. 1996 Feb;153(2):231-7
pubmed: 8561204
Am J Respir Crit Care Med. 2009 Dec 1;180(11):1092-7
pubmed: 19745202
Crit Care. 2012 Sep 27;16(5):R169
pubmed: 23016926
JAMA. 2018 Feb 20;319(7):680-690
pubmed: 29466591
Cochrane Database Syst Rev. 2017 Feb 16;2:MR000033
pubmed: 28207928
Ann Intern Med. 2007 Aug 21;147(4):273-4
pubmed: 17638716
Crit Care. 2013 Mar 18;17(2):R47
pubmed: 23506796
J Nutr Health Aging. 2016;20(9):927-936
pubmed: 27791223
Intensive Care Med. 2010 Jun;36(6):926-39
pubmed: 20376429
Crit Care Med. 2013 Aug;41(8):1983-91
pubmed: 23863230
J Clin Epidemiol. 2016 Jan;69:225-34
pubmed: 26092286
Intensive Care Med. 2010 Sep;36(9):1505-13
pubmed: 20376430
J Clin Exp Neuropsychol. 1998 Jun;20(3):310-9
pubmed: 9845158
BMC Med Res Methodol. 2014 Nov 21;14:120
pubmed: 25416419
Neuropsychol Rev. 2004 Jun;14(2):87-98
pubmed: 15264710
JAMA. 2012 Mar 21;307(11):1151-60
pubmed: 22436955
Crit Care Med. 2013 Sep;41(9 Suppl 1):S30-8
pubmed: 23989093
Crit Care. 2009;13(3):R75
pubmed: 19454032
Semin Clin Neuropsychiatry. 2000 Apr;5(2):75-85
pubmed: 10837096
J Contin Educ Health Prof. 2006 Winter;26(1):55-62
pubmed: 16557512
Crit Care. 2013 Jan 17;17(1):R9
pubmed: 23327295
J Am Geriatr Soc. 2006 Mar;54(3):479-84
pubmed: 16551316
J Crit Care. 2017 Apr;38:190-196
pubmed: 27936404
Surg Today. 2014 Dec;44(12):2305-13
pubmed: 24532143
Syst Rev. 2016 Dec 7;5(1):211
pubmed: 27923397
J Cardiothorac Vasc Anesth. 2014 Dec;28(6):1459-66
pubmed: 25034724
Crit Care Med. 2004 Nov;32(11):2254-9
pubmed: 15640638
Crit Care Med. 2012 Mar;40(3):731-9
pubmed: 22067628
Lancet Respir Med. 2013 Sep;1(7):515-23
pubmed: 24461612
Lancet. 2014 Mar 8;383(9920):911-22
pubmed: 23992774
Lancet. 2010 Nov 27;376(9755):1829-37
pubmed: 21056464
Crit Care Med. 2010 Feb;38(2):428-37
pubmed: 20095068
Crit Care Med. 2012 Jan;40(1):112-8
pubmed: 21926597
BMC Med Res Methodol. 2009 Dec 30;9:86
pubmed: 20042080
Cochrane Database Syst Rev. 2015 Jan 06;1:CD010269
pubmed: 25879090
J Clin Epidemiol. 2016 Feb;70:38-44
pubmed: 26261004
J Cardiothorac Vasc Anesth. 2013 Oct;27(5):933-8
pubmed: 23791495

Auteurs

Marija Barbateskovic (M)

Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Centre for Research in Intensive Care, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Sara Russo Krauss (SR)

Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Marie Oxenboell Collet (MO)

Centre for Research in Intensive Care, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Department of Intensive Care, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Laura Krone Larsen (LK)

Department of of Neuroanaesthesiology, Rigshospitalet, Copenhagen University hospital, Copenhagen, Denmark.

Janus Christian Jakobsen (JC)

Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Centre for Research in Intensive Care, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Department of Cardiology, Holbaek Hospital, Holbaek, Denmark.

Anders Perner (A)

Centre for Research in Intensive Care, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Department of Intensive Care, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Jørn Wetterslev (J)

Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Centre for Research in Intensive Care, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH